Sectors
BGLC
BioNexus Gene Lab Corp.
1.59
1 x 1.39
6 x 1.60
bid
ask
-
0.04
2.67%
08:44 AM
timesize
| Ytd | -59.84% | |
| 1y | -68.89% |
1.59
day range
1.59
1.07
52 week range
8.98
| Open | 1.59 | Prev Close | 1.63 | Low | 1.59 | High | 1.59 | Mkt Cap | 3.28M |
| Vol | 592.00 | Avg Vol | 99.31K | EPS | -1.49 | P/E | -1.09 | Forward P/E | N/A |
| Beta | 4.08 | Short Ratio | 2.21 | Inst. Own | 0.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.08 | 200-d Avg | 3.13 | 1yr Est | 0.00 |
| Income Statement | |||
| Cost of Revenue | -23.63K | ||
| Gross Profit | 23.63K | ||
| Operating Expenses | 597.39K | ||
| Research and Development Expense | 14.49K | ||
| Selling, General and Administrative Expense | 380.40K | ||
| Operating Income | -573.75K | ||
| Interest Expense | 3.09K | ||
| Net Income | -543.58K | ||
| Net Income Common Stock | -543.58K | ||
| Net Income Common Stock (USD) | -543.58K | ||
| Consolidated Income | -543.58K | ||
| Earnings per Basic Share | -0.22 | ||
| Earnings per Basic Share (USD) | -0.22 | ||
| Earnings per Diluted Share | -0.22 | ||
| Earning Before Interest & Taxes (EBIT) | -540.49K | ||
| Earning Before Interest & Taxes (USD) | -540.49K | ||
| Weighted Average Shares | 2.42M | ||
| Weighted Average Shares Diluted | 2.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.34M | ||
| Cash and Equivalents (USD) | 1.34M | ||
| Investments | 4.66M | ||
| Investments Current | 2.63M | ||
| Investments Non-Current | 2.03M | ||
| Trade and Non-Trade Receivables | 168.84K | ||
| Current Assets | 5.20M | ||
| Property, Plant & Equipment Net | 1.82M | ||
| Total Assets | 9.04M | ||
| Debt Current | 196.22K | ||
| Total Debt | 346.62K | ||
| Current Liabilities | 796.47K | ||
| Debt Non-Current | 150.41K | ||
| Total Liabilities | 946.88K | ||
| Accumulated Retained Earnings (Deficit) | -6.97M | ||
| Accumulated Other Comprehensive Income | -98.85K | ||
| Shareholders Equity | 8.09M | ||
| Shareholders Equity (USD) | 8.09M | ||
| Assets Non-Current | 3.84M | ||
| Total Debt (USD) | 346.62K | ||
| Deferred Revenue | 8.42K | ||
| Inventory | 667.15K | ||
| Liabilities Non-Current | 150.41K | ||
| Trade and Non-Trade Payables | 2.14K | ||
| Tax Assets | 61.61K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 43.88K | ||
| Net Cash Flow from Financing | 59.71K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -88.41K | ||
| Capital Expenditure | -325.00 | ||
| Issuance (Repayment) of Debt Securities | 59.71K | ||
| Net Cash Flow from Investing | -13.99K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -13.66K | ||
| Net Cash Flow from Operations | -147.67K | ||
| Effect of Exchange Rate Changes on Cash | 13.54K | ||